STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc announced the purchase and cancellation of 1,400,000 ordinary shares of \u00A3.01 each under the second tranche of its buyback programme. The purchases occurred on 12 August 2025 on the London Stock Exchange with a highest price of 356.1000p, lowest of 353.2000p and a volume weighted average price of 354.8037p.

After settlement the company reports registered share capital of 8,977,135,788 ordinary shares, of which 3,880,205 are held as treasury shares, leaving 8,973,255,583 ordinary shares with voting rights. The announcement includes a breakdown of individual trades under the Market Abuse Regulation and provides links for shareholders to verify holdings for FCA notification thresholds.

Haleon plc ha annunciato l'acquisto e la cancellazione di 1,400,000 azioni ordinarie del valore nominale di £0.01 ciascuna nell'ambito della seconda tranche del suo programma di riacquisto. Gli acquisti sono stati effettuati il 12 agosto 2025 alla London Stock Exchange con un prezzo massimo di 356.1000p, minimo di 353.2000p e prezzo medio ponderato per il volume di 354.8037p.

Dopo il regolamento la società riporta un capitale sociale registrato di 8,977,135,788 azioni ordinarie, di cui 3,880,205 detenute come azioni proprie (in tesoreria), lasciando 8,973,255,583 azioni ordinarie con diritto di voto. L'annuncio include il dettaglio delle singole operazioni ai sensi del Regolamento sugli abusi di mercato (Market Abuse Regulation) e fornisce collegamenti per consentire agli azionisti di verificare le partecipazioni rispetto alle soglie di notifica della FCA.

Haleon plc anunció la compra y la cancelación de 1,400,000 acciones ordinarias con un valor nominal de £0.01 cada una en el marco de la segunda tranche de su programa de recompra. Las compras se realizaron el 12 de agosto de 2025 en la Bolsa de Londres con un precio máximo de 356.1000p, mínimo de 353.2000p y un precio medio ponderado por volumen de 354.8037p.

Tras la liquidación, la compañía declara un capital social registrado de 8,977,135,788 acciones ordinarias, de las cuales 3,880,205 están en autocartera, quedando 8,973,255,583 acciones ordinarias con derecho a voto. El anuncio incluye un desglose de las operaciones individuales conforme al Market Abuse Regulation y facilita enlaces para que los accionistas verifiquen sus participaciones respecto a los umbrales de notificación de la FCA.

Haleon plc는 자사 주식 환매 프로그램의 두 번째 트랜치에서 1,400,000주 보통주(액면가 £0.01)를 매입·소각했다고 발표했습니다. 매수는 2025년 8월 12일 런던증권거래소에서 이루어졌으며, 최고가 356.1000p, 최저가 353.2000p, 거래량 가중 평균가격 354.8037p였습니다.

결제 후 회사는 등록 발행주식수가 8,977,135,788 보통주이며, 그중 3,880,205주는 자사주로 보유 중이라고 보고했습니다. 이에 따라 의결권을 가진 주식수는 8,973,255,583주입니다. 공시는 개별 거래 내역을 시장남용규정(Market Abuse Regulation)에 따라 상세히 제시하며, 주주들이 FCA 공시 임계치를 확인할 수 있는 링크도 제공합니다.

Haleon plc a annoncé l'achat et l'annulation de 1,400,000 actions ordinaires d'une valeur nominale de £0.01 chacune dans le cadre de la deuxième tranche de son programme de rachat. Les achats ont eu lieu le 12 août 2025 à la Bourse de Londres, avec un cours le plus élevé de 356.1000p, le plus bas de 353.2000p et un cours moyen pondéré par le volume de 354.8037p.

Après règlement, la société indique un capital social inscrit de 8,977,135,788 actions ordinaires, dont 3,880,205 sont détenues en propres, laissant 8,973,255,583 actions ordinaires avec droit de vote. L'annonce comprend le détail des opérations individuelles conformément au Market Abuse Regulation et fournit des liens permettant aux actionnaires de vérifier leurs participations par rapport aux seuils de notification de la FCA.

Haleon plc hat den Erwerb und die Vernichtung von 1,400,000 Stammaktien mit einem Nennwert von £0.01 je Aktie im Rahmen der zweiten Tranche seines Rückkaufprogramms bekanntgegeben. Die Käufe erfolgten am 12. August 2025 an der London Stock Exchange mit einem Höchstpreis von 356.1000p, einem Tiefstpreis von 353.2000p und einem volumengewichteten Durchschnittspreis von 354.8037p.

Nach dem Settlement weist das Unternehmen ein eingetragenes Aktienkapital von 8,977,135,788 Stammaktien aus, davon werden 3,880,205 als eigene Aktien gehalten, sodass 8,973,255,583 stimmberechtigte Aktien verbleiben. Die Mitteilung enthält eine Aufschlüsselung der Einzeltransaktionen gemäß der Market Abuse Regulation und verweist auf Links, mit denen Aktionäre ihre Beteiligungen gegenüber den Meldegrenzen der FCA prüfen können.

Positive
  • Executed buyback: Company purchased and cancelled 1,400,000 ordinary shares under the second tranche of its buyback programme.
  • Transparent disclosure: Provided trade-level prices and VWAP (354.8037p) and updated registered capital and voting share counts for FCA notification purposes.
Negative
  • None.

Insights

TL;DR: Haleon executed a small tranche-two buyback of 1.4M shares at a VWAP of 354.8037p; impact on capital structure is minimal.

The company purchased and cancelled 1,400,000 ordinary shares on 12 August 2025 at a VWAP of 354.8037p. Relative to the reported registered share capital of 8,977,135,788 shares, this tranche represents approximately 0.016% of the register, indicating the transaction is operationally routine and unlikely to materially affect per-share metrics or capital ratios on its own. The filing supplies full trade breakdowns per MAR, supporting regulatory transparency.

TL;DR: The buyback was disclosed with required regulatory detail and updated share counts; procedural compliance appears documented.

Haleon disclosed that the 1.4M shares were purchased for cancellation under an announced programme and provided updated figures for registered capital, treasury shares and voting shares. The announcement references a full individual trade breakdown under MAR and points shareholders to the company website, which aligns with disclosure requirements for share purchases and shareholder notification rules under the FCA. No governance issues or deviations from routine disclosure are evident in the text provided.

Haleon plc ha annunciato l'acquisto e la cancellazione di 1,400,000 azioni ordinarie del valore nominale di £0.01 ciascuna nell'ambito della seconda tranche del suo programma di riacquisto. Gli acquisti sono stati effettuati il 12 agosto 2025 alla London Stock Exchange con un prezzo massimo di 356.1000p, minimo di 353.2000p e prezzo medio ponderato per il volume di 354.8037p.

Dopo il regolamento la società riporta un capitale sociale registrato di 8,977,135,788 azioni ordinarie, di cui 3,880,205 detenute come azioni proprie (in tesoreria), lasciando 8,973,255,583 azioni ordinarie con diritto di voto. L'annuncio include il dettaglio delle singole operazioni ai sensi del Regolamento sugli abusi di mercato (Market Abuse Regulation) e fornisce collegamenti per consentire agli azionisti di verificare le partecipazioni rispetto alle soglie di notifica della FCA.

Haleon plc anunció la compra y la cancelación de 1,400,000 acciones ordinarias con un valor nominal de £0.01 cada una en el marco de la segunda tranche de su programa de recompra. Las compras se realizaron el 12 de agosto de 2025 en la Bolsa de Londres con un precio máximo de 356.1000p, mínimo de 353.2000p y un precio medio ponderado por volumen de 354.8037p.

Tras la liquidación, la compañía declara un capital social registrado de 8,977,135,788 acciones ordinarias, de las cuales 3,880,205 están en autocartera, quedando 8,973,255,583 acciones ordinarias con derecho a voto. El anuncio incluye un desglose de las operaciones individuales conforme al Market Abuse Regulation y facilita enlaces para que los accionistas verifiquen sus participaciones respecto a los umbrales de notificación de la FCA.

Haleon plc는 자사 주식 환매 프로그램의 두 번째 트랜치에서 1,400,000주 보통주(액면가 £0.01)를 매입·소각했다고 발표했습니다. 매수는 2025년 8월 12일 런던증권거래소에서 이루어졌으며, 최고가 356.1000p, 최저가 353.2000p, 거래량 가중 평균가격 354.8037p였습니다.

결제 후 회사는 등록 발행주식수가 8,977,135,788 보통주이며, 그중 3,880,205주는 자사주로 보유 중이라고 보고했습니다. 이에 따라 의결권을 가진 주식수는 8,973,255,583주입니다. 공시는 개별 거래 내역을 시장남용규정(Market Abuse Regulation)에 따라 상세히 제시하며, 주주들이 FCA 공시 임계치를 확인할 수 있는 링크도 제공합니다.

Haleon plc a annoncé l'achat et l'annulation de 1,400,000 actions ordinaires d'une valeur nominale de £0.01 chacune dans le cadre de la deuxième tranche de son programme de rachat. Les achats ont eu lieu le 12 août 2025 à la Bourse de Londres, avec un cours le plus élevé de 356.1000p, le plus bas de 353.2000p et un cours moyen pondéré par le volume de 354.8037p.

Après règlement, la société indique un capital social inscrit de 8,977,135,788 actions ordinaires, dont 3,880,205 sont détenues en propres, laissant 8,973,255,583 actions ordinaires avec droit de vote. L'annonce comprend le détail des opérations individuelles conformément au Market Abuse Regulation et fournit des liens permettant aux actionnaires de vérifier leurs participations par rapport aux seuils de notification de la FCA.

Haleon plc hat den Erwerb und die Vernichtung von 1,400,000 Stammaktien mit einem Nennwert von £0.01 je Aktie im Rahmen der zweiten Tranche seines Rückkaufprogramms bekanntgegeben. Die Käufe erfolgten am 12. August 2025 an der London Stock Exchange mit einem Höchstpreis von 356.1000p, einem Tiefstpreis von 353.2000p und einem volumengewichteten Durchschnittspreis von 354.8037p.

Nach dem Settlement weist das Unternehmen ein eingetragenes Aktienkapital von 8,977,135,788 Stammaktien aus, davon werden 3,880,205 als eigene Aktien gehalten, sodass 8,973,255,583 stimmberechtigte Aktien verbleiben. Die Mitteilung enthält eine Aufschlüsselung der Einzeltransaktionen gemäß der Market Abuse Regulation und verweist auf Links, mit denen Aktionäre ihre Beteiligungen gegenüber den Meldegrenzen der FCA prüfen können.


UNITED STATES 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
13 August 2025 - “Transaction in Own Shares”
 
 
99.1
 
 
Haleon plc: Transaction in own shares
 
13 August 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 1,400,000 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
12 August 2025
12 August 2025
12 August 2025
Number of Shares purchased:
1,400,000
-
-
Highest price paid per Share (p):
356.1000
-
-
Lowest price paid per Share (p):
353.2000
-
-
Volume weighted average price paid per Share (p):
354.8037
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,977,135,788 ordinary shares of £0.01 each, of which 3,880,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,973,255,583 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/0708V_1-2025-8-12.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: August 13, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What exactly did Haleon (HLN) buy back?

Haleon purchased and cancelled 1,400,000 ordinary shares of \\u00A3.01 each.

When and where were the shares purchased?

The purchases occurred on 12 August 2025 on the London Stock Exchange.

What prices did Haleon pay for the shares?

Highest price paid was 356.1000p, lowest was 353.2000p, and the VWAP was 354.8037p.

How many shares does Haleon have after the transaction?

Registered share capital is 8,977,135,788 ordinary shares; 3,880,205 are treasury shares; shares with voting rights total 8,973,255,583.

Where can I find the full breakdown of individual trades?

A full breakdown is available via the link quoted in the announcement and on Haleon"http://www.rns-pdf.londonstockexchange.com/rns/0708V_1-2025-8-12.pdf" and on the company website at www.haleon.com/investors.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

42.99B
4.49B
0.02%
12.67%
0.49%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United Kingdom
Weybridge